Meiji Holdings Co Ltd
TSE:2269

Watchlist Manager
Meiji Holdings Co Ltd Logo
Meiji Holdings Co Ltd
TSE:2269
Watchlist
Price: 3 129 JPY -0.22% Market Closed
Market Cap: 883B JPY
Have any thoughts about
Meiji Holdings Co Ltd?
Write Note

Gross Margin
Meiji Holdings Co Ltd

29.7%
Current
31%
Average
23.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
29.7%
=
Gross Profit
333.1B
/
Revenue
1.1T

Gross Margin Across Competitors

Country JP
Market Cap 864.3B JPY
Gross Margin
30%
Country JP
Market Cap 53.2T JPY
Gross Margin
34%
Country CH
Market Cap 190.5B CHF
Gross Margin
47%
Country US
Market Cap 80.2B USD
Gross Margin
39%
Country ZA
Market Cap 45.5B Zac
Gross Margin
28%
Country FR
Market Cap 41.2B EUR
Gross Margin
48%
Country MY
Market Cap 167.6B MYR
Gross Margin
22%
Country US
Market Cap 37B USD
Gross Margin
35%
Country ZA
Market Cap 35.9B Zac
Gross Margin
42%
Country CN
Market Cap 258.3B CNY
Gross Margin
35%
Country US
Market Cap 35.2B USD
Gross Margin
35%
No Stocks Found

Meiji Holdings Co Ltd
Glance View

Market Cap
864.3B JPY
Industry
Food Products

Meiji Holdings Co., Ltd. has long been a staple in the world of Japanese consumer goods, specifically in the food and pharmaceutical sectors. Established in 2009 as a result of merging Meiji Seika Kaisha, Ltd. and Meiji Dairies Corporation, the company stands as a testament to the power of strategic consolidation, leveraging over a century of expertise from its predecessors. The company's robust product portfolio spans a diverse array of offerings, including dairy products like yogurts and milk, confectioneries like chocolate and candy, as well as nutrition bars and supplements. This triumvirate of product lines allows Meiji Holdings to position itself in both the everyday consumer market and in specialized health-centric industries, exploiting economies of scale and extensive distribution networks that reach far beyond the Japanese archipelago. In the pharmaceutical arena, Meiji Holdings operates under its subsidiary, Meiji Seika Pharma, focusing predominantly on antibacterial drugs, central nervous system treatments, and veterinary products. By integrating research and development with a comprehensive marketing strategy, the company capitalizes on global health trends and regional disease challenges, expanding in markets that emphasize health and dietary improvements. Financially, Meiji Holdings generates revenue by producing goods that tap into both traditional consumer desires and modern nutritional trends. It makes money by introducing high-margin pharmaceutical innovations alongside its well-established consumer brands, thus benefiting from both everyday sales and solutions aimed at pressing global health needs. Together, these strategic components make Meiji Holdings an agile player in a competitive global market, combining heritage with innovation.

Intrinsic Value
4 294.01 JPY
Undervaluation 27%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
29.7%
=
Gross Profit
333.1B
/
Revenue
1.1T
What is the Gross Margin of Meiji Holdings Co Ltd?

Based on Meiji Holdings Co Ltd's most recent financial statements, the company has Gross Margin of 29.7%.